Treatment of MeT-5A cells with other malignant PF samples (M5 and M9) decreased P-PTEN S380 expression compared to treatment with B1 and B2, respectively, indicating that PTEN was more active but less stable. The gene discussed is PTEN; the disease is pemphigus foliaceus.